Oppenheimer reiterated coverage on Turning Point with a new price target

11/10/21 7:43:30 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Oppenheimer reiterated coverage of Turning Point with a rating of Outperform and set a new price target of $115.00 from $150.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$TPTX

Date	Price Target	Rating	Analyst
5/20/2022	$58.00	Buy	BofA Securities
3/1/2022	$50.00 → $45.00	Hold	Stifel
2/10/2022	$120.00 → $85.00	Overweight	Wells Fargo
1/21/2022	$115.00 → $105.00	Outperform	Oppenheimer
12/7/2021		Outperform	Cowen & Co.
11/10/2021	$150.00 → $115.00	Outperform	Oppenheimer
10/12/2021	$178.00 → $162.00	Buy	HC Wainwright & Co.
10/11/2021		Market Outperform → Market Perform	JMP Securities